Research led by Paresh Dandona, MD, PhD, has shown that adding liraglutide to insulin treatment for patients with Type 1 diabetes provides health benefits.


For Catherine Wallace, participation in a clinical trial through the Jacobs School of Medicine and Biomedical Sciences put her on the path to a healthier life.


Paresh Dandona, MD, PhD, has led research showing that taking a fiber supplement can help patients with Type 2 diabetes boost their insulin secretion — even after eating a high-fat, high-carbohydrate meal.


Pinaki Sarder, PhD, assistant professor of pathology and anatomical sciences, has received a grant from the National Institute of Diabetes and Digestive and Kidney Diseases’ Diabetic Complications Consortium to study the computational imaging of renal structures for diagnosing diabetic nephropathy.


A global study led by Paresh Dandona, MD, PhD, found a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels.


Children with Type 2 diabetes, including those who are obese, tend to have poorer oral health than other children, according to a first-of-its-kind study.


The Department of Medicine’s Division of General Internal Medicine had a strong showing at the 2017 Society of General Internal Medicine (SGIM) annual meeting with 11 research posters and one oral presentation.


Giving oral dextrose gel to hypoglycemic newborns reduces the need for IV fluids, alleviating health care costs while promoting bonding and breast-feeding, according to Satyan Lakshminrusimha, MD, professor and vice chair of pediatrics and chief of the Division of Neonatology.


Researchers in the Division of Endocrinology, Diabetes and Metabolism have found that dapagliflozin, designed for Type 2 diabetes, can benefit patients with Type 1 diabetes.


A study led by Paresh Dandona, MD, PhD, and published online in Diabetes Care shows overweight and obese Type 1 diabetics saw the most significant improvements — including a reduction in blood sugar — in a randomized clinical trial of liraglutide.


Leonard H. Epstein, PhD, SUNY Distinguished Professor in the Department of Pediatrics, has been awarded a $2.4 million National Institutes of Health (NIH) grant to study how implementing self-regulation helps prevent prediabetes patients from becoming diabetic.


A study led by Paresh Dandona, MD, PhD, has demonstrated that men with Type 2 diabetes who have low testosterone levels can benefit significantly from testosterone treatment.


Paresh Dandona, MD, PhD, has been appointed to serve on the editorial board of Diabetes Care, the official journal of the American Diabetes Association. 


Family Medicine faculty are playing key roles in a $5.8 million clinical trial to improve care and outcomes for patients with coexisting diabetes, hypertension and chronic kidney disease.


Nitesh D. Kuhadiya, MD, MPH, assistant professor of medicine, has received the Helmsley Charitable Trust Abstract Award from the Endocrine Society for his groundbreaking research that shows significant improvements in glucose control in patients with Type 1 diabetes.


The D-Link support group, founded and run by University at Buffalo medical students, has been helping adolescents and young adults deal with the complexities of Type 1 diabetes since 2006.


Roberto O. Diaz Del Carpio, MD, MPH, has won the inaugural Evan Calkins, MD Fellowship for Community Based Research for his project addressing the spectrum of needs for diabetes patients through shared medical visits.

For obese patients with Type 1 diabetes, a key measure of diabetes control improves when liraglutide is added to insulin, according to a new University at Buffalo study.
A diet that includes plentiful low-fat dairy foods improves measures of insulin resistance, according to a study by University at Buffalo researchers and their Canadian colleagues.

A UB study shows that insulin injections exert a strong anti-inflammatory effect at the cellular and molecular level in Type 1 diabetics.